Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Nausea and Vomiting|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer
Interventions: DRUG: palonosetron hydrochloride|DRUG: cyclophosphamide|DRUG: dexamethasone|DRUG: doxorubicin hydrochloride|PROCEDURE: quality-of-life assessment|PROCEDURE: nausea and vomiting therapy|PROCEDURE: management of therapy complications|DRUG: ondansetron hydrochloride|OTHER: survey administration
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)